These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 18297707

  • 41. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
    Said ZN, El-Sayed MH, El-Bishbishi IA, El-Fouhil DF, Abdel-Rheem SE, El-Abedin MZ, Salama II.
    Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
    [Abstract] [Full Text] [Related]

  • 42. HBV and HCV infection in Japanese dental care workers.
    Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M.
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [Abstract] [Full Text] [Related]

  • 43. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Bartolomé J, Pardo M, Carreño V.
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [Abstract] [Full Text] [Related]

  • 44. Occult HBV infection in hemodialysis setting is marked by presence of isolated antibodies to HBcAg and HCV.
    Di Stefano M, Volpe A, Stallone G, Tartaglia L, Prato R, Martinelli D, Pastore G, Gesualdo L, Fiore JR.
    J Nephrol; 2009 Mar; 22(3):381-6. PubMed ID: 19557715
    [Abstract] [Full Text] [Related]

  • 45. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.
    Fang Y, Shang QL, Liu JY, Li D, Xu WZ, Teng X, Zhao HW, Fu LJ, Zhang FM, Gu HX.
    J Infect; 2009 May; 58(5):383-8. PubMed ID: 19329189
    [Abstract] [Full Text] [Related]

  • 46. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, Khadem-Sadegh A, Velayati AA.
    Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
    [Abstract] [Full Text] [Related]

  • 47. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK.
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [Abstract] [Full Text] [Related]

  • 48. Occult hepatitis B virus in liver tissue of individuals without hepatic disease.
    Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, Di Vita G, Scisca C, Squadrito G, Pollicino T.
    J Hepatol; 2008 May; 48(5):743-6. PubMed ID: 18314221
    [Abstract] [Full Text] [Related]

  • 49. Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C.
    Shetty K, Hussain M, Nei L, Reddy KR, Lok AS.
    Liver Transpl; 2008 Apr; 14(4):534-40. PubMed ID: 18324677
    [Abstract] [Full Text] [Related]

  • 50. Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea.
    Kim SM, Lee KS, Park CJ, Lee JY, Kim KH, Park JY, Lee JH, Kim HY, Yoo JY, Jang MK.
    J Infect; 2007 Feb; 54(2):185-91. PubMed ID: 16564573
    [Abstract] [Full Text] [Related]

  • 51. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR.
    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A.
    Intervirology; 2007 Feb; 50(4):241-4. PubMed ID: 17446712
    [Abstract] [Full Text] [Related]

  • 52. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission.
    El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, Abdel-Sattar RM, Ahmady AM, El-Nakeeb A.
    Transfus Med; 2008 Feb; 18(1):55-61. PubMed ID: 18279193
    [Abstract] [Full Text] [Related]

  • 53. Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases.
    Georgiadou SP, Zachou K, Rigopoulou E, Liaskos C, Mina P, Gerovasilis F, Makri E, Dalekos GN.
    J Viral Hepat; 2004 Jul; 11(4):358-65. PubMed ID: 15230859
    [Abstract] [Full Text] [Related]

  • 54. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection.
    Ranki M, Schätzl HM, Zachoval R, Uusi-Oukari M, Lehtovaara P.
    Hepatology; 1995 Jun; 21(6):1492-9. PubMed ID: 7768492
    [Abstract] [Full Text] [Related]

  • 55. Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen.
    Ramia S, Mokhbat J, Ramlawi F, El-Zaatari M.
    Int J STD AIDS; 2008 Mar; 19(3):197-9. PubMed ID: 18397562
    [Abstract] [Full Text] [Related]

  • 56. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
    Hsia CC, Scudamore CH, Di Bisceglie AM, Tabor E.
    J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
    [Abstract] [Full Text] [Related]

  • 57. Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes.
    Selim HS, Abou-Donia HA, Taha HA, El Azab GI, Bakry AF.
    Eur J Intern Med; 2011 Apr; 22(2):187-90. PubMed ID: 21402251
    [Abstract] [Full Text] [Related]

  • 58. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study.
    Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Ahmadi F, Razeghi E, Atabak S, Amini M, Khadem-Sadegh A, Ramezani A.
    Ther Apher Dial; 2010 Jun; 14(3):349-53. PubMed ID: 20609190
    [Abstract] [Full Text] [Related]

  • 59. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.
    Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, Giuberti T, Orlandini A, Raffa G, Pollicino T, Raimondo G, Ferrari C, Missale G.
    Gastroenterology; 2008 May; 134(5):1470-81. PubMed ID: 18355815
    [Abstract] [Full Text] [Related]

  • 60. Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users.
    Ferreira RC, Rodrigues FP, Teles SA, Lopes CL, Motta-Castro AR, Novais AC, Souto FJ, Martins RM.
    J Med Virol; 2009 Apr; 81(4):602-9. PubMed ID: 19235862
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.